6H90 Stock Chart & Stats
€0.49
<€0.01(0.25%)
At close: 4:00 PM EDT
€0.49
<€0.01(0.25%)
Day’s Range― - ―
52-Week Range€0.34 - €0.99
Previous CloseN/A
Volume31.00K
Average Volume (3M)3.64K
Market Cap
€141.69M
Enterprise Value€287.49M
Total Cash (Recent Filing)€39.81M
Total Debt (Recent Filing)€84.51M
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding305,398,500
10 Day Avg. Volume6,062
30 Day Avg. Volume3,639
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.18Price Target Upside141.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.03
Revenue Forecast (FY)€86.01M
Bulls Say, Bears Say
Bulls Say
Strong Revenue ScalingThe sharp first-half revenue increase demonstrates meaningful scale expansion and broader commercial reach following the Orion acquisition. If integrated effectively, the larger revenue base can support cross-selling, improve operating leverage, and provide a stronger foundation for recurring enterprise growth over the next several quarters.
Platform Scale And Clinical ReachA large installed data and provider footprint can strengthen HEALWELL’s competitive position by supporting broader clinical coverage, product validation, and distribution. The reported identification of more than 62,000 high-risk patients also provides evidence that the platform is being applied to measurable care-delivery outcomes.
Enterprise Recurring ModelThe shift from smaller pilots toward larger enterprise licenses could improve contract durability, revenue visibility, and customer retention when deployments mature. Cross-selling across the Orion legacy base may also increase monetization of existing relationships without requiring equivalent expansion in customer-acquisition costs.
Bears Say
Persistent UnprofitabilityDespite improved revenue and narrower losses, the company has not yet demonstrated durable profitability. Continued net losses limit internally funded investment, weaken shareholder returns, and make future performance dependent on successful execution of margin initiatives and sustained growth in higher-value software revenue.
Negative Free Cash FlowNegative operating and free cash flow indicate that the current business is not yet consistently self-funding. Although operating cash burn improved from 2025, continued cash consumption can constrain product investment and capital allocation, while the weaker recent free-cash-flow trend leaves the path to sustainable cash generation uncertain.
Execution And Revenue Timing RiskLong enterprise sales cycles can delay contract conversion and revenue recognition, making growth less predictable across reporting periods. In parallel, incomplete integration synergies and ongoing technology-debt reduction mean the expected margin benefits remain execution-dependent and may take roughly 1.5 years to fully realize.
HEALWELL AI News
6H90 FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was €0.34 and its highest was €0.98 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is €141.69M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Nov 16, 2026 which is in 15 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on Aug 07, 2026. The company reported €0.013 earnings per share for the quarter, beating the consensus estimate of -€0.016 by €0.029.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.02.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 305,398,500 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of €0.013 in its last earnings report, beating expectations of -€0.016. Following the earnings report the stock price went up 6.5%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in DE:6H90
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€1.18 (141.08% Upside)
€1.18 (141.08% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.10%
12-Months-Change
Fundamentals
Return on Equity
-23.76%
Trailing 12-Months
Asset Growth
-10.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
6H90 Stock 12 Month Forecast
Average Price Target
€1.18
▲(141.08% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―